CLDN6 and cancer: In their study, CLDN6-enriched GACs expressed high levels of cancer/germline antigens (MAGE-A, -B), which were originally detected to be dysregulated in melanoma cells and have been linked to TP53 degradation, aggressive tumor growth, and a poorer prognosis [31].